ProHealth health Vitamin and Natural Supplement Store and Health
Home  |  Log In  |  My Account  |  View Cart  View Your ProHealth Vitamin and Supplement Shopping Cart
800-366-6056  |  Contact Us  |  Help
Facebook Google Plus
Fibromyalgia  Chronic Fatigue Syndrome & M.E.  Lyme Disease  Natural Wellness  Supplement News  Forums  Our Story
Store     Brands   |   A-Z Index   |   Best Sellers   |   New Products   |   Deals & Specials   |   Under $10   |   SmartSavings Club

Trending News

10 Fibro-Friendly Foods with a Bonus: Beautiful Skin

Fight Back! Win the War Being Waged Against Your Immune System

Studies Show that Magnesium L-threonate Improves Brain Plasticity, Leading to Direct and Significant...

The role of microbiota and intestinal permeability in the pathophysiology of autoimmune and neuroimm...

Clary Sage Oil May Be Pricey, but Its Benefits Are Priceless

Component of red wine, grapes can help to reduce inflammation, study finds

Poly MVA: A Novel Therapy for Increasing Energy, Repairing DNA, and Promoting Overall Health

Pumpkin Pie Turmeric Breakfast Smoothie - Vegan + Gluten-Free

Omega-3 fatty acid stops known trigger of lupus

What’s Fenugreek Good For?

Print Page
Email Article

Method Used by COX-2 Enzymes in Development of Colon Cancer Described by UCSD Medical Researchers

  [ 122 votes ]   [ Discuss This Article ] • June 30, 2003

The precise molecular interactions that allow cyclooxygenase-2 (COX-2) enzymes to promote the development of colon cancer have been described for the first time by researchers at the University of California, San Diego (UCSD) School of Medicine.

In lab studies with human and rat cells, the investigators defined the multiple steps initiated by COX-2, including a prominent role for a molecule called cyclic adenosine monophosphate (cAMP) and proteins called Inhibitors of Apoptosis (IAPs). The result of these molecular interactions is suppression of the body's natural cell-killing process, resulting in uncontrolled cell growth and eventual colon cancer.

Published online the week of June 30, 2003 in the journal Proceedings of the National Academy of Sciences, the findings also explain how aspirin and other nonsteroidal anti-inflammatory drugs (NSAIDs) can reduce the incidence of colon cancer by inhibiting COX-2 and allowing the body to resume its normal process of killing unwanted or harmful cells.

Although colon cancer was studied, the findings have potential implications for understanding non-intestinal cancers where COX-2 or related enzymes play a role similar to that in colorectal cancer, said the paper's senior author, Paul Insel, M.D., UCSD professor of pharmacology and medicine. These may include certain lung cancers, prostate cancer, head and neck squamous cell carcinomas, and some breast cancers.

In addition, by pinpointing each step in the molecular chain-of-events initiated by COX-2 enzymes, the study offers potential new targets for drug therapies that have fewer side effects than NSAIDs, which can cause problems such as stomach irritation.

Prior to these findings, researchers have known that one of the earliest molecular events in 80 percent of colon cancers is over expression of COX-2 enzymes. Although clinical studies have provided unequivocal evidence that long-term use of NSAIDs inhibited COX-2 enzymes and was associated with a 40 to 50 percent reduction in the incidence of colon cancers, the precise mechanism of action was not understood.

Lars Eckmann, M.D., UCSD assistant professor of medicine and a co-author of the paper, explained that researchers have known that normal cell death is inhibited in colon cancer, resulting in overgrowth of harmful cells. The new findings determine how this happens.

In the intestines and other tissue, cells are generated and then die by a normal process called apoptosis. In the normal intestine, cells originate deep within the tissue, then migrate to the surface, where they undergo apoptotic cell death. In colon cancer, however, the cells "hang around too long and forget how to die," Eckmann explained.

A complicated process, apoptosis is a result of balanced molecular actions taking place at two different starting points. An "extrinsic" pathway, also called the death receptor pathway, activates one set of molecules. A second, "intrinsic" pathway is mediated by small cellular organelles called mitochondria. Like a letter "Y," the two pathways meet and join as they cause chemical reactions down a final pathway, resulting in a specific cell's death.

The research team headed by Insel and Eckmann used sophisticated laboratory analysis to determine that apoptosis was interrupted by IAP, an Inhibitor of Apoptosis Protein, at the point where the two pathways merge.

Specifically, the inhibition of apoptosis begins when COX-2 enzymes lead to the formation of prostaglandins, hormone-like chemical messengers that normally act as cell regulators for smooth muscle relaxation and regulation of blood pressure. On the road to colon cancer, however, prostaglandins trigger an increased production of cAMP, which is known to stimulate a variety of cellular activities. In this case, cAMP is able to block apoptosis on both pathways by activating IAPs.

The study was funded by grants from the National Institutes of Health, the Rebecca and John Moores UCSD Cancer Center, and the Stein Institute for Research on Aging. In addition to Insel and Eckmann, authors of the paper were first author Hiroshi Nishihara, M.D., Ph.D., UCSD Department of Pharmacology, and Shinae Kizaka-Kondoh, M.D., Ph.D., Department of Molecular Oncology, Kyoto University Graduate School of Medicine, Japan.

Post a Comment

Featured Products From the ProHealth Store
Ultra EPA  - Fish Oil Mitochondria Ignite™ with NT Factor® Vitamin D3 Extreme™

Looking for Vitamins, Herbs and Supplements?
Search the ProHealth Store for Hundreds of Natural Health Products

Article Comments

Be the first to comment on this article!

Post a Comment

Natural Pain Relief Supplements

Featured Products

Energy NADH™ 12.5mg Energy NADH™ 12.5mg
Improve Energy & Cognitive Function
FibroSleep™ FibroSleep™
The All-in-One Natural Sleep Aid
Mitochondria Ignite™ with NT Factor® Mitochondria Ignite™ with NT Factor®
Reduce Fatigue up to 45%
Vitamin D3 Extreme™ Vitamin D3 Extreme™
50,000 IU Vitamin D3 - Prescription Strength
Ultra EPA  - Fish Oil Ultra EPA - Fish Oil
Ultra concentrated source of essential fish oils

Natural Remedies

Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value Olea25 Olive Hydroxytyrosol Hits Astonishing 68,000+ ORAC Antioxidant Value
Natural Support for Mood, Sleep and Mental Focus? L-theanine Natural Support for Mood, Sleep and Mental Focus? L-theanine
Repair Damaged Mitochondria and Reduce Fatigue Up to 45% Repair Damaged Mitochondria and Reduce Fatigue Up to 45%
The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS The Crucial Role CoQ10 Plays in Fibromyalgia and ME/CFS
Prepare Yourself for Cold & Flu Season Prepare Yourself for Cold & Flu Season

ProHealth, Inc.
555 Maple Ave
Carpinteria, CA 93013
(800) 366-6056  |  Email

· Become a Wholesaler
· Vendor Inquiries
· Affiliate Program
Credit Card Processing
Be the first to know about new products, special discounts and the latest health news. *New subscribers only

CONNECT WITH US ProHealth on Facebook  ProHealth on Twitter  ProHealth on Pinterest  ProHealth on Google Plus

© 2016 ProHealth, Inc. All rights reserved. Pain Tracker App  |  Store  |  Customer Service  |  Guarantee  |  Privacy  |  Contact Us  |  Library  |  RSS  |  Site Map